Log in or Sign up for Free to view tailored content for your specialty!
Pneumonia News
Reduced mechanical ventilation risk with corticosteroids in community-acquired pneumonia
Fewer patients with community-acquired pneumonia using corticosteroids vs. standard care needed mechanical ventilation, but mortality rates did not differ between both groups, according to study results published in CHEST.
LAMA/LABA therapy reduced risk for COPD exacerbation, pneumonia hospitalization
A long-acting muscarinic antagonist plus long-acting beta agonist (LABA) was linked to fewer COPD exacerbations and pneumonia hospitalizations vs. an inhaled corticosteroid and LABA, according to results published in JAMA Internal Medicine.
Log in or Sign up for Free to view tailored content for your specialty!
FDA approves new treatment for nosocomial pneumonia
The FDA has approved IV sulbactam-durlobactam to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex.
FDA approves first vaccine against RSV
The FDA on Wednesday approved the world’s first vaccine against respiratory syncytial virus, which followed years of failed attempts by scientists to develop one.
Algorithm helps predicts pneumonia risk among patients with multiple myeloma
A nurse-created algorithm helped determine which patients with multiple myeloma exhibited the highest risk for pneumonia, according to study results.
FDA grants 510(k) clearances to triage, notification findings on chest, head imaging
The FDA has granted 510(k) clearances to seven triage and notification findings of varying conditions on chest X-ray and head CT images, according to a manufacturer-issued press release.
Machine-learning model superior in community-acquired pneumonia mortality prediction
A machine-learning model showed excellent discriminative ability in predicting 30-day mortality in patients with community-acquired pneumonia, according to study results published in CHEST.
Hydrocortisone lowers risk from severe pneumonia, study finds
People with severe community-acquired pneumonia who were treated with hydrocortisone had a lower risk for death 28 days after diagnosis compared with those who received placebo, a phase 3 trial found.
P. jirovecii pneumonia prophylaxis use in lupus ‘much lower’ than prior studies suggest
The real-world use of Pneumocystis jirovecii pneumonia prophylaxis in patients with systemic lupus erythematous is “much lower” than prior survey-based studies suggest, according to data published in Seminars in Arthritis and Rheumatism.
Q&A: Pediatric pneumonia severity risk tool aims to provide ‘safer, more effective care’
The lack of an established tool to predict disease severity among children with pneumonia may lead to ineffective management decisions, according to a press release from Ann & Robert H. Lurie Children’s Hospital of Chicago.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read